Martin A. Lehr's most recent trade in Context Therapeutics Inc was a trade of 100,000 Common Stock done at an average price of $0.7 . Disclosure was reported to the exchange on June 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Context Therapeutics Inc | Martin A. Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.70 per share. | 09 Jun 2025 | 100,000 | 920,190 | - | 0.7 | 70,080 | Common Stock |
| Context Therapeutics Inc | Martin A. Lehr | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 802,700 | 802,700 | - | - | Stock Option (right to buy) |